8.25
price down icon1.79%   -0.15
after-market Dopo l'orario di chiusura: 8.73 0.48 +5.82%
loading
Precedente Chiudi:
$8.40
Aprire:
$8.28
Volume 24 ore:
315.02K
Relative Volume:
3.41
Capitalizzazione di mercato:
$262.73M
Reddito:
$193.67M
Utile/perdita netta:
$4.82M
Rapporto P/E:
17.93
EPS:
0.46
Flusso di cassa netto:
$15.53M
1 W Prestazione:
+1.35%
1M Prestazione:
+4.96%
6M Prestazione:
-10.13%
1 anno Prestazione:
-21.13%
Intervallo 1D:
Value
$8.21
$8.72
Intervallo di 1 settimana:
Value
$8.13
$8.72
Portata 52W:
Value
$7.15
$13.77

Zynex Inc Stock (ZYXI) Company Profile

Name
Nome
Zynex Inc
Name
Telefono
(800)-495-6670
Name
Indirizzo
9655 MAROON CIRCLE, ENGLEWOOD, CO
Name
Dipendente
1,101
Name
Cinguettio
@zynexmedical
Name
Prossima data di guadagno
2024-10-24
Name
Ultimi documenti SEC
Name
ZYXI's Discussions on Twitter

Confronta ZYXI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
9.30 0 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.72 372.90M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.1402 295.87M 2.07B -1.42B -1.37B -0.6765
 icon
MOBBW
Mobilicom Limited Warrants
0.6475 278.60M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.32 142.97M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
4.01 52.16M 0 0 0 0.00

Zynex Inc Stock (ZYXI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-10-16 Iniziato RBC Capital Mkts Outperform
2023-01-06 Aggiornamento Piper Sandler Neutral → Overweight
2022-02-28 Reiterato B. Riley Securities Buy
2021-07-16 Aggiornamento B. Riley Securities Neutral → Buy
2021-03-09 Aggiornamento Northland Capital Market Perform → Outperform
2021-02-26 Downgrade B. Riley Securities Buy → Neutral
2021-01-29 Downgrade Piper Sandler Overweight → Neutral
2021-01-28 Downgrade Northland Capital Outperform → Market Perform
2020-09-14 Aggiornamento H.C. Wainwright Neutral → Buy
2020-09-09 Aggiornamento Northland Capital Market Perform → Outperform
2020-07-29 Aggiornamento B. Riley FBR Neutral → Buy
2020-07-20 Iniziato Piper Sandler Overweight
2020-07-13 Downgrade B. Riley FBR Buy → Neutral
2020-07-10 Reiterato H.C. Wainwright Neutral
2020-06-16 Downgrade Northland Capital Outperform → Market Perform
2020-05-19 Downgrade H.C. Wainwright Buy → Neutral
2020-04-01 Iniziato Northland Capital Outperform
2019-09-23 Iniziato H.C. Wainwright Buy
Mostra tutto

Zynex Inc Borsa (ZYXI) Ultime notizie

pulisher
Dec 19, 2024

Electrotherapy System Market Future Business Opportunities - openPR

Dec 19, 2024
pulisher
Dec 18, 2024

How to Take Advantage of moves in (ZYXI) - Stock Traders Daily

Dec 18, 2024
pulisher
Dec 18, 2024

Zynex partners with VA to expand pain management access By Investing.com - Investing.com Canada

Dec 18, 2024
pulisher
Dec 17, 2024

Zynex partners with VA to expand pain management access - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex's SWOT analysis: pain management firm's stock faces growth hurdles By Investing.com - Investing.com Canada

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex's SWOT analysis: pain management firm's stock faces growth hurdles - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex partners with VA to offer pain management solutions for veterans - Proactive Investors

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States (PR Newswire) - Aktiellt

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex partners with Veterans Affairs Medical Centers to deliver noninvasive pain relief solutions - Proactive financial news

Dec 17, 2024
pulisher
Dec 16, 2024

Zynex, Inc. Sets Second Quarter 2023 Earnings Call - GuruFocus.com

Dec 16, 2024
pulisher
Dec 13, 2024

Zynex Announces Completion of Its Laser Pulse Oximetry Trial - The Eastern Progress Online

Dec 13, 2024
pulisher
Dec 13, 2024

Zynex CEO outlines plans for 2025 after revenue milestone – ICYMI - Proactive financial news

Dec 13, 2024
pulisher
Dec 12, 2024

Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters - The Malaysian Reserve

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex to Present at the HC Wainwright Global Investment Conference - The Eastern Progress Online

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex UCSF Study Results Demonstrate Laser Technology Benefits i - GuruFocus.com

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex study highlights precision of laser-based pulse oximeter in reducing racial bias - Proactive Investors USA

Dec 12, 2024
pulisher
Dec 12, 2024

ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial - MSN

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters – Company AnnouncementFT.com - Financial Times

Dec 12, 2024
pulisher
Dec 11, 2024

Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates - MSN

Dec 11, 2024
pulisher
Dec 10, 2024

Zynex Sets Third Quarter 2024 Earnings Call - Longview News-Journal

Dec 10, 2024
pulisher
Dec 09, 2024

Zynex Inc. Achieves $200M Milestone and Sets Ambitious Goals for 2025 - Proactive Investors UK

Dec 09, 2024
pulisher
Dec 09, 2024

Non Invasive Pain Management Devices Market Overall Study - openPR

Dec 09, 2024
pulisher
Dec 07, 2024

Objective long/short (ZYXI) Report - Stock Traders Daily

Dec 07, 2024
pulisher
Dec 07, 2024

Zynex's (ZYXI) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Dec 07, 2024
pulisher
Dec 06, 2024

CHIEF FINANCIAL OFFICER Moorhead Daniel J was granted 5,000 shares and covered exercise/tax liability with 4,879 shares, decreasing direct ownership by 42% to 35,561 units (SEC Form 4) - Quantisnow

Dec 06, 2024
pulisher
Dec 06, 2024

Zynex stock retains buy rating on FDA progress - Investing.com

Dec 06, 2024
pulisher
Dec 06, 2024

Zynex stock retains buy rating on FDA progress By Investing.com - Investing.com Canada

Dec 06, 2024
pulisher
Dec 06, 2024

Zynex completes clinical verification trial of pulse oximeter - Yahoo Finance

Dec 06, 2024
pulisher
Dec 06, 2024

Muscle Stimulator Market Next Big Thing | Major Giants- Axiobionics, Zynex, NeuroMetrix - openPR

Dec 06, 2024
pulisher
Dec 06, 2024

Hotchkis & Wiley Capital Management LLC Raises Holdings in Zynex, Inc. (NASDAQ:ZYXI) - MarketBeat

Dec 06, 2024
pulisher
Dec 06, 2024

Zynex completes trial for new pulse oximeter technology By Investing.com - Investing.com Canada

Dec 06, 2024
pulisher
Dec 05, 2024

Laser-Based Pulse Oximeter Advances Toward FDA Submission - Sleep Review

Dec 05, 2024
pulisher
Dec 05, 2024

Zynex eyes FDA submission for NiCO pulse oximeter following successful verification trial - Proactive Investors Australia

Dec 05, 2024
pulisher
Dec 05, 2024

Zynex completes trial for new pulse oximeter technology - Investing.com

Dec 05, 2024
pulisher
Dec 05, 2024

Zynex Completes Breakthrough Clinical Trial for Next-Gen Laser Pulse Oximeter at Duke University - StockTitan

Dec 05, 2024
pulisher
Dec 04, 2024

Zynex Announces Open Oximetry Project Membership - GuruFocus.com

Dec 04, 2024
pulisher
Dec 03, 2024

Zynex CFO Daniel Moorhead sells $80,800 in company stock By Investing.com - Investing.com Nigeria

Dec 03, 2024
pulisher
Dec 03, 2024

Insider Sell Alert: Daniel Moorhead Sells 10,000 Shares of Zynex Inc (ZYXI) - GuruFocus.com

Dec 03, 2024
pulisher
Dec 03, 2024

Zynex CFO Daniel Moorhead sells $80,800 in company stock - Investing.com

Dec 03, 2024
pulisher
Dec 03, 2024

Zynex joins Open Oximetry Project as it advances innovative NiCO pulse oximeter - Proactive Investors Australia

Dec 03, 2024

Zynex Inc Azioni (ZYXI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Zynex Inc Azioni (ZYXI) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 14 '24
Sale
8.09
2,000
16,180
14,603,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 12 '24
Sale
9.24
2,000
18,480
14,607,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 07 '24
Sale
9.17
2,000
18,340
14,613,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 11 '24
Sale
9.09
2,000
18,180
14,609,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 08 '24
Sale
8.77
2,000
17,540
14,611,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 13 '24
Sale
8.37
2,000
16,740
14,605,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 06 '24
Sale
8.82
2,000
17,640
14,615,662
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 04 '24
Sale
8.67
2,000
17,340
14,619,350
Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Nov 05 '24
Sale
8.05
2,000
16,100
14,617,662
MOORHEAD DANIEL J
CHIEF FINANCIAL OFFICER
Nov 01 '24
Sale
8.59
10,000
85,900
44,878
$2.19
price down icon 0.23%
medical_distribution YI
$0.88
price up icon 16.96%
medical_distribution AHG
$1.23
price up icon 3.36%
medical_distribution OMI
$12.52
price down icon 0.79%
$30.86
price down icon 0.16%
Capitalizzazione:     |  Volume (24 ore):